A 52-week phase 2 trial on AMG133 in people with overweight and obesity is ongoing (NCT05669599)
Timing matters: administer MIC injections on the same weekly schedule as GLP-1 injections (typically the day after) to align peak lipotropic support with the period of maximum dietary fat mobilization
Research findings, protocols, benefits, and safety from FormBlends
If you remember from our BPC-157 dosage article (if you haven't read it yet, here's your chance to demystify BPC-157), it works best close to the injury
It means the evidence we have today has not identified a consistent pattern of serious adverse events directly attributable to BPC-157
Best for: those focused on skin firmness, wound healing, reduced inflammation, and fuller hair